Clinical Trials Logo

Filter by:
NCT ID: NCT03606252 Completed - Clinical trials for Pneumonia, Pneumocystis

Specialized Proresolving Mediators in Pneumocystis Jirovecii Pneumonia

INFLA-PCP
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate specialized proresolving mediators (SPM) concentrations for the first time in subjects infected with Pneumocystis jirovecii. SPM will be measured in blood and urine in patients with favourable or unfavourable outcome of Pneumocystis pneumonia and in patients colonized by Pneumocystis jirovecii. The hypothesis is that low levels of SPM in the blood could be predictive of a negative outcome of pneumocystosis.

NCT ID: NCT03605979 Completed - Type 1 Diabetes Clinical Trials

Continuous Glucose Monitoring and Hypoglycemia Unawareness in Type 1 Diabetes

Start date: July 1, 2012
Phase:
Study type: Observational

Looking for strict normoglycemia in type 1 diabetes increases the risk of hypoglycemia, exposing to hypoglycemia unawareness. It has been shown that the early correction of hypoglycemia can help recovering the perception of hypoglycemia. The purpose of this prospective study was to assess the value of sensor-augmented insulin-pump therapy to treat hypoglycemia unawareness.

NCT ID: NCT03605316 Completed - Clinical trials for Obsessive-compulsive Disorder (OCD)

Deep Electrical Neuromodulation in Obsessive-compulsive Disorder

NEP-TOC
Start date: April 1, 2018
Phase:
Study type: Observational

Obsessive-compulsive disorder (OCD) is a neuropsychiatric disease characterised by intrusive, recurrent and persistent thoughts, urges or images (obsessions) and the resulting excessive repetitive behaviours or mental acts according to rigid rules unrealistically aimed at reducing distress (compulsions). Its lifetime prevalence in the general population is usually estimated between 1 - 3% (Ruscio, Mol Psychiatry, 2010). Despite appropriate pharmacological and cognitive-behavioural treatments, it is commonly estimated that 10% of patients are therapy-refractory and that among improved or recovered patients, sustained efficacy is uncertain. For treatment refractory OCD patients, a neurosurgical treatment by deep brain stimulation (DBS), has emerged in the late 1990s as a new therapeutic option (Nuttin et al, Lancet, 1999). The objective of the current study is to report the long-term treatment effects (safety and effectiveness) of DBS from the cohort of six severe and therapy-refractory OCD patients implanted at the French university hospital of Montpellier since 2003.

NCT ID: NCT03604757 Completed - Prostate Cancer Clinical Trials

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

UROPET
Start date: April 25, 2018
Phase: Phase 2
Study type: Interventional

Patients with primary prostate cancer (low, intermediate or high metastatic risk) for whom radical prostatectomy is indicated, will be invited to participate to the present study. Positron Emission Tomography coupled with scanner (PET-CT) using a radiotracer : 68Ga-RM2 and Positron Emission Tomography coupled with scanner (PET-CT) using another radiotracer : 68Ga-PSMA-617, will be scheduled.

NCT ID: NCT03604510 Completed - Tourette Syndrome Clinical Trials

Role of Frontal Cortex in the Pathophysiology of Gilles de la Tourette Syndrome (GTS)

TIC-EEG
Start date: February 2, 2018
Phase: N/A
Study type: Interventional

Tourette's syndrome (TS) is a debilitating and severe syndrome whose pathophysiology remains unclear. In order to precise the cortical regions involved in the generation of tics, investigators will realize an electroencephalogram (EEG) recording in the frontal cortex of TS patients in ecological conditions (EEG-holter). Activity changes will be correlated with event markers of tics and neurovegetative parameters. Statistical analyses will be compared between epochs of EEG recording with tics and without tics. The aim is to define the cortical regions involved in the genesis of tics in order to consider new targets for cortical stimulation.

NCT ID: NCT03604120 Completed - Clinical trials for Intubation;Difficult

Preoxygenation for Difficult Airway Management

PREOPTI-DAM
Start date: September 19, 2018
Phase: N/A
Study type: Interventional

Tracheal intubation in operating room for patients at risk of difficult intubation remains a critical event. The aim of this study is to determine whether Nasal High Flow Therapy by nasal cannula Optiflow® administered before and during intubation is more efficient than the standard care for pre-oxygenation and oxygenation during anticipated difficult intubation

NCT ID: NCT03604042 Completed - Weight Gain Clinical Trials

Comparison of Two Dose Adjustment Strategies of a Human Milk Protein Fortifier in Preterm Infants

Start date: October 9, 2017
Phase: N/A
Study type: Interventional

The primary objective is to compare weight gain (g/day) of infants receiving new protein fortifier (PF) according to a blood urea nitrogen (BUN)-driven fortification regimen to weight gain (g/day) of infants receiving PF according to a weight-driven fortification regimen (standard of care) over a 21 day period.

NCT ID: NCT03603873 Completed - Anxiety Clinical Trials

Preoperative Anxiety Level, Premedications and General Anaesthetic Proceedings

Start date: March 3, 2017
Phase:
Study type: Observational

Although it seems obvious that the high level of preoperative anxiety may affect intraoperative anaesthetic requirements and recovery adversely, there are several contradictory studies about this subject. Furthermore, the effects of anxiolytic premedication are actually disputed: sedative premedication is widely administered but little clinical evidence supports its use. We want to evaluate the effects of pre-procedure anxiety for propofol needs in patients receiving general anaesthetic procedure. We also want to know if premedication is useful according to the preoperative anxiety level, in order to determine if a sub-group of patients benefit from it.

NCT ID: NCT03603847 Completed - Clinical trials for Anaplastic Large Cell Lymphoma, ALK-Positive

Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma

Start date: August 2, 2018
Phase:
Study type: Observational

The study aims to evaluate the prognostic value on the complete metabolic response rate (MCR), the incidence of relapse / progression, the Progression Free Survival (PFS) and the Overall Survival (OS). - at diagnosis - after the first cycle of CHOEP (early evaluation) - at the end of treatment

NCT ID: NCT03603470 Completed - Hip Fractures Clinical Trials

Total Hip Arthroplasty Instability and Lumbo-pelvic Kinematics: EOS Imaging Assessment of Variation in Spinal and Pelvic Parameters From Standing to Sitting

HIPEOS
Start date: July 6, 2018
Phase: N/A
Study type: Interventional

The authors hypothesize that a pelvic kinematic disorder, demonstrated by a significant decrease in sacral slope, is associated with the risk of instability of total hip prosthesis, the sacral slope being measured by an EOS imaging system during the transition to sitting in unstable patients versus patients with no history of instability.